Weekly chemoradiation (docetaxel/cisplatin) followed by surgery in stage III NSCLC; a multicentre phase II study.
Maas
Klaartje W
KW
Department of Pulmonary Diseases, St. Antonius Hospital Nieuwegein, Nieuwegein, the Netherlands. kwmaas@hotmail.com
El Sharouni
Sherif Y
SY
Phernambucq
Erik C J
EC
Stigt
Jos A
JA
Groen
Harry J M
HJ
Herder
Gerarda J M
GJ
Van Den Borne
Ben E E M
BE
Senan
Suresh
S
Paul
Marinus A
MA
Smit
Egbert F
EF
Schramel
Franz M N H
FM
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000628:therapy*; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D000077143:Docetaxel; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011878:Radiotherapy / Q000009:adverse effects; D015996:Survival Rate; D043823:Taxoids / Q000008:administration & dosage
D043823:Taxoids; D000077143:Docetaxel; D002945:Cisplatin